Jacobs Levy Equity Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-64,425
| Closed | -$238K | – | 1126 |
|
|
2017
Q4 | $238K | Buy |
+64,425
| New | +$238K | ﹤0.01% | 874 |
|
|
2017
Q2 | – | Sell |
-12,400
| Closed | -$51K | – | 1078 |
|
|
2017
Q1 | $51K | Buy |
+12,400
| New | +$51K | ﹤0.01% | 897 |
|
|
2016
Q4 | – | Sell |
-19,222
| Closed | -$189K | – | 1122 |
|
|
2016
Q3 | $189K | Sell |
19,222
-24,300
| -56% | -$239K | ﹤0.01% | 919 |
|
|
2016
Q2 | $246K | Sell |
43,522
-23,750
| -35% | -$134K | 0.01% | 948 |
|
|
2016
Q1 | $513K | Buy |
67,272
+56,172
| +506% | +$428K | 0.01% | 722 |
|
|
2015
Q4 | $148K | Hold |
11,100
| – | – | ﹤0.01% | 720 |
|
|
2015
Q3 | $182K | Sell |
11,100
-33,852
| -75% | -$555K | ﹤0.01% | 721 |
|
|
2015
Q2 | $1.01M | Sell |
44,952
-44,543
| -50% | -$1,000K | 0.02% | 465 |
|
|
2015
Q1 | $875K | Buy |
89,495
+64,033
| +251% | +$626K | 0.01% | 503 |
|
|
2014
Q4 | $290K | Buy |
25,462
+14,894
| +141% | +$170K | 0.01% | 691 |
|
|
2014
Q3 | $122K | Buy |
+10,568
| New | +$122K | ﹤0.01% | 786 |
|